0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Trials |  April 01, 2013
Can We Stop Mass Drug Administration Prior to 3 Annual Rounds in Communities With Low Prevalence of Trachoma?:  PRET Ziada Trial Results
Jithin Yohannan, BA; Beatriz Munoz, MS; Harran Mkocha, BS; et al.
JAMA Ophthalmol. 2013;131(4):431-436. doi:10.1001/jamaophthalmol.2013.2356.
INCLUDES: , Supplemental Content
Special Article |  March 01, 2012 FREE
Vincent (Ċensu) Tabone, an Ophthalmologist and a President of the Republic of Malta
Robert M. Feibel, MD
Arch Ophthalmol. 2012;130(3):373-377. doi:10.1001/archophthalmol.2011.291.
Research Letters |  April 11, 2011 FREE
Slow Resolution of Clinically Active Trachoma Following Successful Mass Antibiotic Treatments
Jeremy D. Keenan, MD, MPH; Takele Lakew, MD, MPH; Wondu Alemayehu, MD, MPH; et al.
Arch Ophthalmol. 2011;129(4):512-526. doi:10.1001/archophthalmol.2011.46.
Special Article |  April 11, 2011 FREE
Fred Loe, MD, and the History of Trachoma
Robert M. Feibel, MD
Arch Ophthalmol. 2011;129(4):503-508. doi:10.1001/archophthalmol.2011.64.
Ophthalmological Numismatics |  February 01, 2011
Victor Deneffe
Arch Ophthalmol. 2011;129(2):172. doi:10.1001/archophthalmol.2010.374.
Research Letters |  January 01, 2010 FREE
Cost Analysis of Povidone-Iodine for Ophthalmia Neonatorum Prophylaxis
Arch Ophthalmol. 2010;128(1):136-137. doi:10.1001/archophthalmol.2009.365.
Editorial |  October 13, 2008
Global Blindness:  VISION 2020: The Right to Sight
Suresh R. Chandra, MD
Arch Ophthalmol. 2008;126(10):1457. doi:10.1001/archopht.126.10.1457.
Ophthalmological Numismatics |  October 13, 2008
Jean Fierens
Arch Ophthalmol. 2008;126(10):1468. doi:10.1001/archopht.126.10.1468.
Commentary |  May 01, 2005
Systemic Antibiotics for Communitywide Trachoma Control
Alfred Sommer, MD, MHS
Arch Ophthalmol. 2005;123(5):687-688. doi:10.1001/archopht.123.5.687.
Epidemiology |  April 01, 2004 FREE
Risk Factors for Recurrence of Postoperative Trichiasis:  Implications for Trachoma Blindness Prevention
Hui Zhang, MS; Ram P. Kandel, MPH; Bassant Sharma, MD; et al.
Arch Ophthalmol. 2004;122(4):511-516. doi:10.1001/archopht.122.4.511.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Neurology
Observation  |  June 3, 2013
Elevated CSF Cytokines in the Jarisch-Herxheimer Reaction of General Paresis
Larry E. Davis, MD; Ryan Oyer, MD; J. David Beckham, MD; et al.
JAMA Internal Medicine
Research Letters  |  May 13, 2013
Adult Mortality in a Randomized Trial of Mass Azithromycin for Trachoma
Jeremy D. Keenan, MD, MPH; Paul M. Emerson, PhD; Bruce D. Gaynor, MD; et al.
JAMA
Global Health  |  April 17, 2013
Congenital Syphilis Estimates
M. J. Friedrich
JAMA
From the Centers for Disease Control and Prevention  |  April 10, 2013
CDC Grand Rounds: The Growing Threat of Multidrug-Resistant Gonorrhea
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems